Advertisment Fericit Banner
Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback |  Login  
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives | Ahead of print | Search | Instructions Editorial Board   

Users Online: 155

Official publication of the Indian Society of Nephrology
Indian Journal of Nephrology (IJN)

The Indian Journal of Nephrology is the official publication of the Indian Society of Nephrology. The journal is published Bimonthly. It is a peer-reviewed, journal that publishes articles covering all the aspects of laboratory and clinical nephrology. It includes original researches, reviews, editorials, technical notes, symposia proceedings, and Society news.

The journal provides immediate free access to articles on its website. It does not charge a fee for submission, processing or publication of the manuscripts. Articles can be submitted online from www.journalonweb.com.




 
  

 

Pubmed

Current Issue RSS Feed for Current Issue
September-October  2016 |  Vol 26 |  Issue 5 |
 
 
Commentary
Rituximab use in late antibody-mediated rejection
SB Bansal
Antibody-mediated rejection (AMR) is an important cause of graft loss after the 1 st year of transplant. [1] The standard treatment of AMR consists of steroid pulses, plasmapheresis (PP), and intraven...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Original Article
Rituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience
M Surendra, SB Raju, N Raju, S Chandragiri, KK Mukku, MS Uppin
Antibody-mediated rejection (AMR) is not uncommon after renal transplantation and is harder to handle compared to cell-mediated rejection. When refractory to conventional therapies, rituximab is an at...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Original Article
Rifampicin and anti-hypertensive drugs in chronic kidney disease: Pharmacokinetic interactions and their clinical impact
A Agrawal, SK Agarwal, T Kaleekal, YK Gupta
Patients on dialysis have an increased incidence of tuberculosis (TB). Rifampicin, a first-line antitubercular therapy (ATT) drug, is a potent inducer of hepatic cytochrome P450 (CYP). There is potent...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Read more....

Table of Contents   Access Statistics

2016 Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07